Inhibited early immunologic response is associated with hypertrophic scarring

Area of Science:

• Wound healing research
• Immunology
• Dermatology

Background:

• Hypertrophic scar formation is linked to the immune system, but the precise mechanisms and timing are unclear.
• Understanding early inflammatory changes is crucial for developing effective scar treatments.

Purpose of the Study:

• To investigate the inflammatory response in early hypertrophic scarring compared to normal wound healing.
• To identify early indicators of hypertrophic scar development.

Main Methods:

• Prospective observational study involving skin biopsies from patients undergoing cardiothoracic surgery.
• Analysis of mRNA, proteins, and cells in early wound healing phases (post-wounding and 3 hours later).
• Correlation of molecular findings with scar outcome (hypertrophic vs. normal) at one year.

Main Results:

• Significant differences in P-selectin mRNA expression between normal and hypertrophic scar groups during surgery.
• Lower postoperative concentrations of inflammatory proteins (IL-6, IL-8, CCL2) in hypertrophic scar patients.
• A trend towards higher pre-operative M2 macrophage numbers in the hypertrophic scar group.

Conclusions:

• Altered wound healing, including a reduced inflammatory protein response, is evident as early as 3 hours post-wounding in hypertrophic scarring.
• Increased P-selectin mRNA may influence leukocyte migration in hypertrophic wound healing.
• Findings suggest a reduced inflammatory response in early hypertrophic scarring, with implications for treatment.